title: Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
authors.forename: D A
authors.initials: DA
authors.lastname: Dance
authors.forename: V
authors.initials: V
authors.lastname: Wuthiekanun
authors.forename: W
authors.initials: W
authors.lastname: Chaowagul
authors.forename: Y
authors.initials: Y
authors.lastname: Suputtamongkol
authors.forename: N J
authors.initials: NJ
authors.lastname: White
mesh_terms: D000658:Amoxicillin / Q000494:pharmacology* / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D016957:Burkholderia pseudomallei / Q000187:drug effects* / Q000302:isolation & purification; D002442:Ceftazidime / Q000494:pharmacology* / Q000627:therapeutic use; D002969:Clavulanic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008554:Melioidosis / Q000188:drug therapy; D008826:Microbial Sensitivity Tests
chemical_list: D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D002442:Ceftazidime